The following advisories have been issued by New York State Office of Mental Health to provide guidance to providers and the general public.
July 20, 2022
People who are receiving antipsychotic medications are at increased risk for heat stroke and neuroleptic malignant syndrome.
January 12, 2022
Before administering Paxlovid to patients who are receiving clozapine and have symptomatic COVID-19, consider the risk factors and information provided in the advisory.
May 18, 2015
OMH has issued a Health Advisory-Clozapine: Managing Constipation and GI Hypomotility in an effort to raise awareness of the approaches for preventing, monitoring and treating constipation and gastrointestinal (GI) hypomotility associated with the use of clozapine.
October 1, 2012
OMH issued a Clinical Advisory regarding discharges from hospitals licensed or operated by the Office of Mental Health (OMH) to certain Adult Homes licensed by the State Department of Health (DOH). After receiving comments regarding the Clinical Advisory, OMH has amended that Clinical Advisory to clarify several issues
August 8, 2012
Clinical Advisory regarding discharges from hospitals licensed or operated by the Office of Mental Health (OMH) to certain Adult Homes licensed by the State Department of Health (DOH
April 29, 2010
The Office of Mental Health recently released guidance for all hospitals under its jurisdiction, on the use of PRN medications. It is intended to replace all previous guidance and policy on this topic, including OMH Official Policy PC-530, "PRN for Agitation." It is effective immediately.
April 29, 2010
This OMH Practice Advisory addresses the use of Electroconvulsive Therapy (ECT) for individuals under the age of 18 years. The Office of Mental Health is distributing it as a directive for all State-operated psychiatric facilities, and as a practice advisory to other mental health care providers in New York State.
September 22, 2007
OMH Guidance on Electroconvulsive Therapy presents a quality review process for State-operated psychiatric centers.
May 16, 2007
The New York State Office of Mental Health provides the attached Advisory on the treatment of children and adolescents with second generation (SGA) (or novel or atypical) antipsychotic medications.
January 13, 2003
Electroconvulsive Therapy Review Guidelines are for use by provider hospitals and facilities, based on the American Psychiatric Association (APA) recommendations.